Mechanical Thrombectomy of Medium Sized Vessels "M2 of MCA".

• Status: Not yet recruiting
• Trial end date: 2022-11-30
• Target enrollment: 0
• Participant gender: All

Summary

Mechanical thrombectomy recently has revolutionized the treatment of stroke. Trials have demonstrated the superiority of mechanical thrombectomy in large vessel occlusions, such as in the intracranialinternal carotid artery and proximal, middle cerebral artery (M1), middle cerebral artery trunk (M1), have relatively high rates of revascularization and favorable clinical outcomes after MT. , However second-order branches of the middle cerebral artery (M2) occlusions (postbifurcation in the Sylvian fissure) were underrepresented or not represented in the trials. Posing a more significant technical challenge to the available endovascular devices because of the smaller size and tortuosity of these arteries and the greater likelihood of recanalization with intravenous thrombolysis, the overall risk-benefit remains uncertain.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University

Criteria

Inclusion Criteria:

• Age >18 years

• Cerebral infarction in anterior circulation involving occlusion of M2 MCA, proven by CTA

• With or without IV thrombolysis

• Access to endovascular treatment within 24 hours from onset.

Exclusion Criteria:

1. Proven proximal occlusion of MCA.

2. Disability prior to the stroke (mRS >3)

3. Opposition of the patient or their family